Happiness is just a gap between sheds Progress Pictures 11/17/2025
A user shared their experience with hair loss treatments, switching from 1mg finasteride and topical minoxidil to 5mg oral minoxidil and oral dutasteride, noting improvements despite shedding phases. Other users discussed the hair growth cycle, treatment effects, and shared advice on managing hair loss, including buzzing hair and maintaining mental health.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity 3 months on min + fin and my hair is shedding way more than before
Hair shedding is common when using minoxidil and finasteride, often indicating that the treatment is working as weaker hairs fall out to make way for stronger growth. Many users experience multiple shedding cycles before seeing significant hair regrowth.
community Taking oral finasteride/minoxidil for about 8 months and now noticing some increased shedding
The user has been taking oral finasteride and minoxidil for about 8 months and is experiencing increased hair shedding, which is considered normal due to synchronized hair cycles. Despite the shedding, the user has seen significant hair regrowth and is advised to continue the treatment as the shedding should subside.
community Losing hairs is not the same as balding
Hair loss treatments like finasteride, dutasteride, and minoxidil can cause initial shedding as they restart the hair growth cycle, but this is not an indicator of treatment failure. The effectiveness of these treatments should be judged by cosmetic changes over time, not by daily hair loss counts.
community Does Dutasteride Significantly Reverse Hair Loss?
Dutasteride, especially at higher doses, is considered more effective than Minoxidil for hair regrowth by blocking DHT, which causes hair loss. Combining Dutasteride with Minoxidil may enhance hair recovery by prolonging the hair growth phase.
community Taking 1mg fin and 2.5mg min since a year now. Hair might be the worst its ever been.
The user has been taking 1mg finasteride and 2.5mg minoxidil for a year, experiencing initial improvement followed by increased hair shedding. Others suggest this could be a second shedding phase, and emphasize patience, as hair treatments can take years to show consistent results.
Related Research
6 / 6 results
research Minoxidil: a comprehensive review
This study reported that while topical minoxidil exhibits hair regrowth in androgenetic alopecia, oral minoxidil 5 mg/day was more effective than topical forms after six months, with low doses also potentially effective for women and other hair loss types.
research Guava (Psidium guajava L.) Leaf Extract as Bioactive Substances for Anti-Androgen and Antioxidant Activities
This study suggests that guava leaf extract may inhibit hair loss by downregulating genes involved in androgen synthesis, potentially offering a natural alternative for treating androgenetic alopecia.
research Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment
This study found that low-dose oral minoxidil 5 mg daily significantly increased hair growth in men with androgenetic alopecia over 24 weeks, with increased hair count and vertex area improvement, though most experienced hypertrichosis and some had pedal edema.
research Overactive bladder in men
This chapter discusses the increasing prevalence of overactive bladder in aging men, examining potential causes and treatment options, without reporting new clinical results.
research Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study
This study found that a topical combination of 0.25% finasteride and 3% minoxidil may increase hair diameter more effectively than 3% minoxidil alone in postmenopausal women with female pattern hair loss.
research Hair Physiology (Hair Growth, Alopecia, Scalp Treatment, etc.)
This article reviews various hair growth and hair loss treatments, noting limited new developments since FDA-approved drugs but highlights recent cosmetic surgery and potential cell-based therapies; it reports no original findings.